Development of new anticancer drugs in Japan--tubulin-interacting agents.
Tsukagoshi
S
S
Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
D000627:Aminophenols / Q000737:chemistry / Q000494:pharmacology*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D004347:Drug Interactions; D005260:Female; D006801:Humans; D007564:Japan; D008297:Male; D009369:Neoplasms / Q000188:drug therapy; D009842:Oligopeptides / Q000737:chemistry / Q000494:pharmacology*; D013449:Sulfonamides / Q000737:chemistry / Q000494:pharmacology*; D014404:Tubulin / Q000494:pharmacology*; D000096926:Benzenesulfonamides
D000627:Aminophenols; D000970:Antineoplastic Agents; D009842:Oligopeptides; D013449:Sulfonamides; D014404:Tubulin; C079199:E 7010; D000096926:Benzenesulfonamides; C105791:soblidotin